Tech / Reel
Tech · Video brief
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
Colossal Biosciences is reportedly in discussions to secure new funding, aiming for a valuation between $20 billion and $30 billion. The startup is generating revenue with its innovative conservation technology, potentially paving the way f...
Video won't play? Watch on YouTube →
Colossal Biosciences is reportedly in discussions to secure new funding, aiming for a valuation between $20 billion and $30 billion. The startup is generating revenue with its innovative conservation technology, potentially paving the way for reintroducing extinct species and biodiversity credits.
Full story and more reels: https://newsreel.video
#news #breaking #biotechnology #investment #conservation
Originally reported by TechCrunch.
Read the full story →
More in Tech
Tech
Tech
Tech
While VCs crowd into San Francisco, Endeavor Catalyst raises $320M for founders ‘elsewhere’
Tech
Tech
Tech
AI chip boom pushes Samsung profits to record $80bn
Tech
Tech
Tech
0 Comments
No comments yet. Be the first.